NaturalPedia > Novartis

Quotes about Novartis from the world's top natural health / natural living authors

 Email this page to a friend   |  Click here for FREE email alerts

page 1 of 4 | Next ->

"With the announcement that zoledronic acid, a bisphosphonate, could be given intravenously once a year for the prevention of osteopenia, the press and novartis stockholders took notice. The fact that bisphosphonates, particularly long-acting bisphosphonates, can cause catastrophic death of the jawbone has hardly squelched the zeal. When Eli Lilly's novel pharmaceutical, a parathyroid hormone fragment, was shown to prevent osteopenia and even diminish the incidence of osteoporotic fractures, medicine and Wall Street took notice. It seems sensible that all this effort be expended." - Nortin M. Hadler MD, Worried Sick: A Prescription for Health in an Overtreated America (Get the book.)

"The failure of many doctors to grasp the drug's toxicity and abuse potential is in part a testimonial to the success of the manufacturer, novartis, in convincing the medical profession that Ritalin is "mild" and relatively harmless. In fact, the misleading description of "mild stimulant" remains in the FDA-approved label to this day. Willow was now nineteen years old and like any addict her life was falling apart. She couldn't stay in school at the community college. She couldn't hold down a job. She lived at home and fought with her mother over the control of her medications." - Peter Breggin, Medication Madness: A Psychiatrist Exposes the Dangers of Mood-Altering Medications (Get the book.) "If I was able to discern the pattern of adverse effects in 1998, then the FDA and the drug manufacturer novartis with their vast resources should also have been able to do so. After I publicized the problem at the 1998 conference, the FDA and the drug companies no longer had any excuse for failing to conduct their own analyses to confirm my observations. Instead, they delayed for nearly a decade." - Peter Breggin, Medication Madness: A Psychiatrist Exposes the Dangers of Mood-Altering Medications (Get the book.)

"Salespeople at novartis had asked two academic scientists, John S. Markowitz and Kennerly S. Patrick, both on the faculty at the Medical University of South Carolina, to write an article for a scientific journal, describing the different medicines for attention deficit disorders and how each one worked. The scientists and executives had sent an outline of the article back and forth, but the corporate managers were not pleased with the draft the academics had recently turned in. So on a crisp September day in Manhattan the executives and scientists met by conference call." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.) "In an attempt to reclaim its supremacy in the market, novartis had introduced its own new version of the drug, which it called Ritalin LA, the initials representing its longer action. The company had sent out press releases when federal regulators approved the new drug, declaring it an "important advance." But inside the company, executives knew they had a problem. Their new brand of medicine was little different from two other time-released pills already selling fast." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.) "Beveridge in The Art of Scientific Investigation Executives at novartis were in a quandary in the fall of 2002. Ritalin, the pill that had changed the way America quieted fidgety children, was no longer a big moneymaker for the company. Prescriptions had fallen so far that only a fraction of the children diagnosed with attention disorders were using the company's white and yellow tablets. The problem wasn't demand. Millions of parents, more than ever before, were giving their children pills to keep them focused and calm in school." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"William Applegate, then from the University of Tennessee, was a principal investigator in a study of a new blood pressure pill, DynaCirc, sponsored by the drug maker Sandoz (now novartis). Not long before a dramatic meeting at which researchers were going to be shown the results of their study, Applegate was offered a $30,000-a-year consulting position with the drug company. He turned down the offer. Then, when he saw the data, he told the Baltimore Sun, "I thought the company was trying to buy my favor and my opinion." It was simple." - John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.)

"One of the most recent is lumiracoxib (Prexige) (which is likely to have been approved by the FDA and to have reached the shelves by the time you are reading this book), a drug developed by novartis that has been specifically assessed for heart-attack risk in comparison to naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET). In this study, 18,325 patients over the age of fifty who had osteoarthritis were randomly given lumiracoxib, ibuprofen, or naproxen for one year. Sixty-four patients on NSAIDS had gastrointestinal bleeding vs." - J. Douglas Bremner, Before You Take that Pill: Why the Drug Industry May Be Bad for Your Health (Get the book.)

"GlaxoSmithKline, Eli Lilly, Pfizer, and novartis all run trials there. Why? Vast numbers of potential research subjects, cheaper costs, and the fact that the patient population is "treatment naive"—they are largely unexposed to drugs, which makes the evaluation of the effect of a given drag easier. India's other advantages include English-speaking medical personnel, lots of hospitals (700,000 specialty beds), and medical colleges (221). But of all these, cost savings is the big one." - Charles Barber, Comfortably Numb: How Psychiatry Is Medicating a Nation (Get the book.) "In response, major sponsors—the drug companies AstraZeneca and novartis, as well as Johnson & Johnson, Scotts Company, and Staples—withdrew their support. Wonderland was gone after two episodes.23 The trend continued in 2007, when General Motors, Volkswagen, and Washington Mutual all ran TV commercials that depicted depressive feelings and suicidal behavior, albeit in satirical ways." - Charles Barber, Comfortably Numb: How Psychiatry Is Medicating a Nation (Get the book.)

"In exchange, novartis gets the first rights to negotiate licenses for about one third of the discoveries made by the department. This includes discoveries funded by novartis as well as those funded by federal and state sources. novartis can also delay the publication of research by up to four months, providing time for patent applications and for allowing the company to utilize the proprietary information. In addition, Novartis gets representation on two of the five seats of the committee that determines how the department's research money is spent." - Jeffrey M. Smith, Seeds of Deception: Exposing Industry and Government Lies about the Safety of the Genetically Engineered Foods You're Eating (Get the book.) "In November 1998, the biotech company novartis gave $25 million to the Department of Plant and Microbial Biology for research. In exchange, novartis gets the first rights to negotiate licenses for about one third of the discoveries made by the department. This includes discoveries funded by novartis as well as those funded by federal and state sources. novartis can also delay the publication of research by up to four months, providing time for patent applications and for allowing the company to utilize the proprietary information." - Jeffrey M. Smith, Seeds of Deception: Exposing Industry and Government Lies about the Safety of the Genetically Engineered Foods You're Eating (Get the book.)

"Wagner has received research support from Abbott, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Organon, Pfizer, and Wyeth-Ayerst; has served as a National Institute of Mental Health consultant to Abbott, Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Laboratories, GlaxoSmithKline, novartis, Otsuka, Janssen, Pfizer, and UCB Pharma; and has participated in speaker's bureaus for Abbott, Eli Lilly, GlaxoSmithKline, Forest Laboratories, Pfizer, and novartis.2 The study's principal statistician was Dr. Ruoyong Yang. Both he and another of the study's authors, Dr." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"Product Information: Ex-Lax®, chocolated laxative pieces. novartis, Summit, NJ, USA, 1998. Product Information: Ex-Lax®, regular and maximum strength laxative pills. novartis, Summit, NJ, USA, 1998. Product Information: SenokotXTRA®, standardized senna concentrate. Purdue Frederick, Norwalk, CT, USA, 1993. Product Information: Senokot®, extract of standardized senna. Purdue Frederick, Norwalk, CT, USA, 1991. Product Information: Senokot®, standardized senna concentrate. Purdue Frederick, Norwalk, CT, USA, 1993. Product Information X-Prep®, extract of standardized senna." - Thomson Healthcare, Inc., PDR for Herbal Medicines, Fourth Edition (Get the book.)

"He had received "educational grants," he said, from AstraZeneca, Janssen, novartis, Solvay Pharmaceuticals, and Tap Pharmaceuticals. He also sat on the advisory boards of GlaxoSmithKline, Sanofi-Synthelabo, and Solvay. Many Iowa physicians learned about Zelnorm from Dr. Rao, even before the drug was approved in 2002. Dr. Dean Abramson, a gastroenterol-ogist with a private practice in Cedar Rapids, said that after listening to a talk by Dr. Rao, he came to believe that Zelnorm would be some kind of wonder drug." - Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"The magazine DER SPIEGEL estimated that novartis paid his top-manager 12.75 million Euros (18.48 million dollars a year), Aventis paid 8.78 37 Zocor is used to reduce the total amounts of LDL (bad) cholesterol, triglycerides (another type of fat) and apolipoprotein B (a protein needed to make cholesterol) in the blood. million Euros (11.6 million dollars), and AstraZeneca paid 4.47 million Euros (6.48 million dollars). But there is more: Families USA researched the highest paid executives of nine pharmaceutical companies. " - Kenneth W Thomas, Ron Gilbert, Gerd Schaller, Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel (Get the book.)

"Pat Morrisey, chief of staff of the Energy and Commerce Committee, took a job lobbying for drug companies novartis and Hoffman-La Roche. Jeremy Allen went to Johnson and Johnson. Kathleen Weldon went to lobby for Biogen, a Bio-tech company. Jim Barnette left to lobby for Hoffman-La Roche. In all, at least 15 congressional staffers, congressmen and federal officials left to go to work for the pharmaceutical industry, whose profits were increased by several billion dollars." - Jonathan W. Emord, The Rise of Tyranny (Get the book.)

"However, the site does mention that the two nonprofit organizations participating in this educational initiative have a number of "corporate partners," namely AstraZeneca, Aventis, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Merck/Schering-Plough, Monarch, novartis, Pfizer, and Wyeth. When corporate partners fund the flow of information, the message is likely to accentuate treatment strategies that are in their interest and downplay those that are not. For example, fewer than one-third of the diabetics in the United States get adequate exercise." - John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.)

"Rejecting the call, the FDA went ahead and approved Zelnorm, but within twelve months the agency sent a letter to novartis describing key advertisements as seriously misleading and asking the company to stop running them.44 The FDA letter took issue with an ad in the New York Times Magazine featuring a couple in a swimming pool. The ad did not name the drug, but rather it described a "Novartis treatment" for IBS, which was clearly Zelnorm." - Ray Moynihan and Alan Cassels, Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All into Patients (Get the book.)

"Eli Lilly, Ancile, Roche, novartis, and Organon; has received research support from the National Institute of Mental Health, Pfizer, Solvay, Eli Lilly, GlaxoSmithKline, Wyeth-Ayerst, Organon, Forest Pharmaceuticals, Inc., PureWorld, Allergan, and Nutrition 2 . . . and has received royalties from MultiHealth Systems, Inc., Guilford Publications and the American Psychiatric Association.56 The Specialty Which Refuses to Disclose Financial Conflicts of Interest I hope you were startled by the research I shared a few pages back (p." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"CHADD received support from novartis, manufacturer of Ritalin; the Human Growth Foundation is at least in part funded by Genentech and Eli Lilly, makers of the hGH drugs; and between 1996 and 1999, NAMI received nearly $12 million from pharmaceutical companies (Sil-verstein, 1999)- Spokespeople from such groups often take strong stances supporting pharmaceutical research and treatment, raising the question of where consumer advocacy begins and pharmaceutical promotion ends. This reflects the power of corporations in shaping and sometimes co-opting advocacy groups." - Peter Conrad, The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders (Get the book.)

"With the announcement that zoledronic acid, a bisphosphonate, could be given intravenously once a year for the prevention of osteopenia, the press and novartis stockholders took notice. When Eli Lilly's new pharmaceutical, a parathyroid hormone fragment, was shown to prevent osteopenia and even diminish the incidence of osteoporotic fractures, medicine and Wall Street took notice. It seems sensible that all this effort be expended, that all white women and maybe others, at the age of sixty-five and maybe younger, rejoice at the progress of science. Social constructions are not "bad." - Nortin M. Hadler, The Last Well Person: How to Stay Well Despite the Health-Care System (Get the book.)

"Eli Lilly and Novartis; S. M. has received research funding from Pfizer; and E. W. has received honoraria for presentations from Eli Lilly.3 literature. So where do they get their knowledge about new drugs? Listen closely to Dr. Avorn's amazing conclusion: Pharmaceutical marketing is about the most important source of knowledge about new drugs for most physicians, and a major form of continuing conditioning as well.43 That is an absolutely startling admission, but perhaps we should not be surprised since the physician-industry relationship is established so early." - Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"Inc.; novartis Pharmaceuticals Corporation; Novo Nordisk Pharmaceuticals; Pfizer Inc; Takeda Pharmaceuticals North America, Inc. • $500,000+; Bayer Corporation; Kraft Foods; Roche Diagnostics Corporation. • $250,000+; Abbott Laboratories, Ross Product Division (Glucerna); AstraZeneca; Merisant U.S., Inc. (Equal Sweetener); Wyeth Pharmaceuticals. • $100,000+: Archway Cookies, LLC; Coolbrands International, Inc. (Eskimo Pie); CVS/pharmacy; General Mills, Inc. (Fiber One); Good Neighbor Pharmacy; KOS Pharmaceuticals, Inc.; Murray Sugar Free Cookies; Ocean Spray Cranberries, Inc." - Anthony Colpo, The Great Cholesterol Con: Why Everything You've been Told About Cholesterol, Diet and Heart Disease is Wrong (Get the book.)

"He also tried Novartis's Meritene for about a year, since this "nutriceutical" formula had been demonstrated in trials with wheelchair-bound elderly to halt bone loss by up to 50%.72 The patient was told of the importance of exercise to stimulate bone growth, and chose regular walking as a safe compromise. In the circumstances, any more violent load-bearing exercise would have been too risky. The patient's bones were regularly monitored (Table 8)." - Michael Gearin-Tosh, Living Proof: A Medical Mutiny (Get the book.)

"Over the same time period, 1999-2003, the FDA's reporting system recorded seven sudden deaths of children taking other ADHD stimulants—Concerta, sold by Johnson & Johnson and Ritalin, made by novartis AG. All three drugs are Schedule II psychostimulants, and all are known to be highly addictive, dangerous and deadly. The FDA MedWatch program, one of voluntary physician reporting, is judged to detect no more than one to ten percent of side effects of a given drug. There were 186 deaths related to methylphenidate/Ritalin between 1990 and 2000." - Fred A. Baughman, Jr., M.D. and Craig Hovey, The ADHD Fraud: How Psychiatry Makes "Patients" of Normal Children (Get the book.)

"And so did the CHADD tribe become the novartis tribe, though no one stated it quite that way. But what was wrong with that? In some ways, nothing. Ritalin was safe, and, as research would show, it improved the performance of kids who did not have ADD as well. Yet, ironically, therein did reside the problem. The drug was still effectively the diagnosis. If it worked, a child had ADD. The result was rampant overprescribing of Ritalin." - Greg Critser, Generation Rx: How Prescription Drugs are Altering American Lives, Minds, and Bodies (Get the book.)

"Without knowing the terms of the licence agreement, it is impossible to know whether novartis or the university gets the better deal. But the example illustrates well the extent to which science needs private money, and vice versa. If the goals of the bioinformatics people are ever to be realized, private money is essential. The goal of a complete model of human biology is vast, arguably unachievable,' say Stephen Warde and Dr Scott Khan of the global computational science company, Accelrys. 'But, in pursuing it, a picture is built that enables more informed discovery." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.) "Aside from shareholders in novartis and other pharma players maybe no one felt relief more keenly than parents whose children are on ADD medication. In an attention-deficit world, in which concentration and any real engagement with the world are the casualties, it can be helpful to have something to take, although most parents would be the first to admit that drugs are hardly ideal. The dynamic that Scruggs identified may well exist but, as the judge ruled, it didn't cause the condition of ADD." - Jacky Law, Big Pharma: Exposing the Global Healthcare Agenda (Get the book.)

page 1 of 4 | Next ->

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalPedia.com

This unique compilation of research is copyright (c) 2008, 2009 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of NaturalPedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.